PSILOCYBIN BILL

WELCOME TO PSILOCYBINBILL.COM

PSILOCYBINBILL.COM is legislative-tracker English: Psilocybin Bill—advocates, lobby desks, and newsletters that already say “the psilocybin bill” when they mean state-house reform cycles, not a clinic Med SKU.

Best-fit buyers: policy nonprofits; state advocacy PACs; journalism hubs; defensive holders. Exact-fit launch: a Psilocybin Bill tracker with bill status tiles, hearing calendar, and donate CTA.

Oregon Psilocybin Services’ 2024 Year in Review counted 31 licensed service centers, 345 facilitators, 11 manufacturers, and 724 worker permits at year-end—the lived regulatory spine behind “psilocybin bill” storytelling.^[1] AdImpact / NBC News put U.S. political advertising near $11 billion in the 2024 cycle—the spend climate issue campaigns already budget against.^[2] That OPS × ad-cycle spine frames why exact Psilocybin Bill inventory matters—not an invented category TAM.

Why Choose PSILOCYBINBILL.COM

• ⚖️ Psilocybin Bill lockup: Legislation English already spoken in statehouses.
• 🌲 Oregon OPS spine: 31 service centers / 345 facilitators YE2024.^[1]
• 📣 Cycle spend: ~$11B U.S. political ads in 2024 (AdImpact).^[2]
• 🔍 Vs Med/clinic names: Bill advocacy ≠ PsilocinMed product doors.
• 🗓️ Session fit: Built for hearing calendars and amendment trackers.
• ✨ Petition clarity: Sounds like the URL on a lobby one-pager.

THE PSILOCYBIN MARKET LANDSCAPE

The numbers tell an undeniable story of opportunity: the psilocybin-assisted therapy market is projected to grow from $3.1 billion in 2025 to $11.8 billion by 2035 at a robust 15.8% CAGR. Three U.S. states—Oregon, Colorado, and New Mexico—are already operating or launching regulated supervised access programs, while nearly 30 more states actively consider similar legislation. With 67% of participants remaining in remission five years after treatment and 23.4% of U.S. adults (61.5 million people) experiencing any mental illness, the demand for innovative platforms has never been greater. PSILOCYBINBILL.COM places you at the intersection of policy, science, and healing—ready to capture this trillion-dollar mental health transformation. 📈🍄

WHAT DOES AVA IVERSON THINK?

"PsilocybinBill.com is legislation-tracker inventory—the bill, not a clinic SKU."

Ava Iverson, Senior Research Analyst

Contact Ava Iverson via Email